Recently, the 7th China Health Industry Upgrading Summit (CHS 2022) hosted by EqualOcean Health was held in Beijing. The summit released the 2022 China Big Health Digital Medical LIST-2022 China Medical Big Data Enterprises TOP10, dHCtech made the list after several rounds of selection.

The list selected by EqualOcean Think Tank and EqualOcean Health for several months aims to find the most innovative and dynamic digital medical enterprises in China, spread industry trends and show industry insights.

" At the end of 2022, as we look back on this year, the challenges of ever-changing digital technologies continue to reshape health care boundaries and create whole new industry increments. In the wave of digital medicine, entrepreneurs follow the trend, but also co-prosperity with the times. The slow-burn nature of medicine has been a thorny and challenging path from the start. They practice their long-term principle in the changeable market environment, and create a world with innovation and wisdom, pumping new life into the industry."

-The above passage comes from EqualOcean

Since its establishment, DHCtech has carried out more than 40 national scientific research and major national projects, becoming the backbone of supporting national technological innovation. In 2022, DHCtech successfully reported and completed a number of national key R&D projects such as the 14^th Five-Year Plan, the 13^th Five-Year Plan and the Science and Technology Innovation 2030. The cooperation units include Peking Union Medical College Hospital, China Medical Academy Cancer Hospital, Southern Hospital of Southern Medical University, Huazhong University of Science and Technology and many other well-known hospitals and universities.

DHCtech insists on building a data standard system according to international standards, focuses on indigenous R&D innovation of independent intellectual property rights, develops a closed loop of fusion-governance-analysis that integrates multi-modal and all-type data such as clinical data, imaging data and histology data, and goes deep into the whole process of clinical screening, diagnosis, governance, management and research, continuously promoting the overall improvement of clinical value and scientific research value of medical institutions.

In the future, DHCtech will continue to focus on four major business areas: medical big data, intelligent imaging platform, precision medicine and digitalization of pharmaceutical companies, and provide all-ecological solutions for the medical and pharmaceutical industries, aiming at creating boundless health with extreme technology and striving to become the world's leading medical big data and artificial intelligence enterprise.